What's more, our result indicated that high expression of G3BP1 protein was identified as an independent poorer prognostic factor for patients with NSCLC, which may provide a new target for the targeted therapy of NSCLC. The gene discussed is G3BP1; the disease is non-small cell lung carcinoma.